Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition

mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4...

Descripción completa

Detalles Bibliográficos
Autores principales: Bray, Kevin, Mathew, Robin, Lau, Alexandria, Kamphorst, Jurre J., Fan, Jing, Chen, Jim, Chen, Hsin-Yi, Ghavami, Anahita, Stein, Mark, DiPaola, Robert S., Zhang, Donna, Rabinowitz, Joshua D., White, Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406086/
https://www.ncbi.nlm.nih.gov/pubmed/22848625
http://dx.doi.org/10.1371/journal.pone.0041831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406086/
https://www.ncbi.nlm.nih.gov/pubmed/22848625
http://dx.doi.org/10.1371/journal.pone.0041831

Ejemplares similares